Climb Bio (CLYM) Earnings Date, Estimates & Call Transcripts $1.26 0.00 (0.00%) As of 02:04 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Climb Bio Earnings Summary Climb Bio issued Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.31, which missed the consensus estimate of -$0.15 by $0.16. With a trailing EPS of -$2.38, Climb Bio's earnings are expected to grow next year, from ($1.57) to ($0.66) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 14) -$0.15 Actual EPS (May. 14) -$0.31 Missed By -$0.16 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)CLYM Upcoming EarningsClimb Bio's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Climb Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Climb Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLYM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Climb Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.15-$0.15-$0.15Q2 20251-$0.18-$0.18-$0.18Q3 20251-$0.19-$0.19-$0.19Q4 20251-$0.21-$0.21-$0.21 Climb Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/14/2025Q1 2025-$0.15-$0.31 -$0.16-$0.31--3/25/2025Q4 2024-$0.15-$0.13+$0.02-$0.13--11/12/2024---$0.13 -$0.13-$0.13-- Climb Bio Earnings - Frequently Asked Questions When is Climb Bio's earnings date? Climb Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on CLYM's earnings history. Did Climb Bio beat their earnings estimates last quarter? In the previous quarter, Climb Bio (NASDAQ:CLYM) missed the analysts' consensus estimate of ($0.15) by $0.16 with a reported earnings per share (EPS) of ($0.31). Learn more on analysts' earnings estimate vs. CLYM's actual earnings. How much profit does Climb Bio generate each year? Climb Bio (NASDAQ:CLYM) has a recorded net income of -$35.12 million. CLYM has generated -$2.38 earnings per share over the last four quarters. What is Climb Bio's EPS forecast for next year? Climb Bio's earnings are expected to grow from ($1.57) per share to ($0.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cryoport Earnings Results Solid Biosciences Earnings Results Phathom Pharmaceuticals Earnings Results Arcturus Therapeutics Earnings Results Terns Pharmaceuticals Earnings Results Neurogene Earnings Results Alpha Teknova Earnings Results Aura Biosciences Earnings Results Heron Therapeutics Earnings Results Aurora Cannabis Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:CLYM) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
